PPARA and prostate carcinoma: Given that LD accumulation in our experimental setting occurred through the GSK3β-PPARα signaling axis downstream of PIM1, we hypothesized that blocking PPARα could counteract the known positive effect of PIM1 induction on cell proliferation in prostate cancer.